NCT07184957Recruiting
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
NYU Langone Health
Start Date
5/1/2017
Completion Date
12/31/2040
Summary
This will be a prospectively maintained research database. The purpose is to record baseline parameters and treatment outcomes following of Cryotherapy for ablation of clinically localized prostate cancer.
Eligibility Criteria
Age Range: 40 years to 85 years
Inclusion Criteria:
* Evidence of focal prostate cancer confined to the prostate based on MRI imaging and prostate biopsy
* Patients with clinically localized prostate cancer (no evidence for or concern for metastatic spread of cancer outside of the prostate) will be counseled regarding treatment options. Those selecting focal Cryo prostate ablation will then be offered inclusion into this data collection.
Exclusion Criteria:
* Men that are not diagnosed with prostate cancer.
* Men that are diagnosed with clinically localized prostate cancer, but select other treatment options as their desired treatment.
Conditions
Prostate Cancer
Locations
NYU Langone Health
New York, New York 10016
United States